Report: Früherkennungsmonitor 2023 (Germany): Difference between revisions
(Created page with "{{forpolicymakers}} Go back to Germany page '''Primary purpose:''' To analyze and provide an overview of the utilization of cancer early detection services offered by the German statutory health insurance (GKV). '''Sponsor, manager or home institution:''' dataOwner::Wissenschaftliches Institut der AOK (WIdO). '''Type of information:''' The report outlines cancer availableVariable::screening services covered by the German statutory health insurance (GKV), i...") |
m (Update categories.) |
||
| Line 1: | Line 1: | ||
<span style="display:none">forpolicymakers</span> | |||
Go back to [[Germany]] page | Go back to [[Germany]] page | ||
| Line 14: | Line 14: | ||
'''Access to information:''' [https://www.wido.de/fileadmin/Dateien/Dokumente/Forschung_Projekte/Ambulante_Versorgung/wido_amb_frueherkennungsmonitor_2023.pdf Click here to access]. | '''Access to information:''' [https://www.wido.de/fileadmin/Dateien/Dokumente/Forschung_Projekte/Ambulante_Versorgung/wido_amb_frueherkennungsmonitor_2023.pdf Click here to access]. | ||
<span style="display:none">Esophagus</span> | |||
<span style="display:none">Stomach</span> | |||
<span style="display:none">Small intestine</span> | |||
<span style="display:none">Large intestine</span> | |||
<span style="display:none">Rectum</span> | |||
<span style="display:none">Anus</span> | |||
<span style="display:none">Liver</span> | |||
<span style="display:none">Gallbladder</span> | |||
<span style="display:none">Bile ducts</span> | |||
<span style="display:none">Pancreas</span> | |||
<span style="display:none">Colon</span> | |||
<span style="display:none">Skin</span> | |||
<span style="display:none">Melanoma</span> | |||
<span style="display:none">Scalp</span> | |||
<span style="display:none">Lips</span> | |||
<span style="display:none">Hands</span> | |||
<span style="display:none">Feet</span> | |||
<span style="display:none">Lobular</span> | |||
<span style="display:none">Vulva</span> | |||
<span style="display:none">Prostate</span> | |||
<span style="display:none">Breast</span> | |||
<span style="display:none">Vagina</span> | |||
<span style="display:none">Testicles</span> | |||
<span style="display:none">Nipple</span> | |||
<span style="display:none">Cervix</span> | |||
<span style="display:none">Penis</span> | |||
<span style="display:none">Areola</span> | |||
<span style="display:none">Uterus</span> | |||
<span style="display:none">Ductal</span> | |||
<span style="display:none">Ovary</span> | |||
<span style="display:none">Fallopian tubes</span> | |||
<span style="display:none">Endometrium</span> | |||
<span style="display:none">dataOwner::Wissenschaftliches Institut der AOK (WIdO)</span> | |||
<span style="display:none">availableVariable::screening</span> | |||
<span style="display:none">availableVariable::diagnosis|cervical</span> | |||
<span style="display:none">availableVariable::medical procedures|preventive</span> | |||
<span style="display:none">availableVariable::number of deaths|cancer mortality</span> | |||
<span style="display:none">availableVariable::cancer incidence</span> | |||
<span style="display:none">availableVariable::check-up examinations|false positives</span> | |||
<span style="display:none">dataLevel::national level</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
Revision as of 13:49, 2 December 2025
Go back to Germany page
Primary purpose: To analyze and provide an overview of the utilization of cancer early detection services offered by the German statutory health insurance (GKV).
Sponsor, manager or home institution: Wissenschaftliches Institut der AOK (WIdO).
Type of information: The report outlines cancer screening services covered by the German statutory health insurance (GKV), including screenings for cervical, prostate, colorectal, breast, and skin cancers, as well as general health checks and screening for abdominal aortic aneurysms. It tracks usage rates of these screenings from 2019 to 2022, noting the impact of the COVID-19 pandemic on participation. A key focus is colorectal cancer screening, analyzing trends in colonoscopy usage for diagnostic and preventive purposes. The report also discusses changes in cancer mortality and cancer incidence in Germany, highlighting declines in certain cancers due to early detection. Additionally, it addresses challenges like false positives and examines regional differences in screening uptake. Click here to learn more.
Data level: national level.
Cancer areas of interest: C15-C26: Digestive system cancers, C43-C44: Skin cancers/melanoma, C50: Breast cancer, C51-C58: Female genitalia cancer, C60-C63: Male genitalia cancer. Click here to learn more.
Access to information: Click here to access.